Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #385710 on Anavex Life Sciences Corp (AVXL)
rayovacAAA
11/28/22 4:07 PM
#385762 RE: Hoskuld #385710
Perhaps Dr. Missling was referring to the time needed to do analysis and presentation. He was very clear in his prepared notes that the trial was on schedule - but the analyst questions tend to provoke responses that lead to questions. All I can tell you is that the company says Excellence is already fully enrolled and will complete by YE2022 and the readout will be Q12023.